Bioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricks

　Percutaneous coronary intervention (PCI) with a drug-eluting stent (DES) is routine treatment for patients with acute coronary syndromes (ACS). However, permanent metallic caging of the vessel has several shortcomings, such as side branch jailing and impossibility of late lumen enlargement.

2016

08-12

A bioresorbable everolimus-eluting scaff old versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II)...

Background Despite rapid dissemination of an everolimus-eluting bioresorbable scaffold for treatment for coronary artery disease, no data from comparisons with its metallic stent counterpart are available. In a randomised controlled trial we aimed to compare an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent. Here we report secondary clinical and procedural outcomes after 1 year of follow-up.

2016

08-12

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment

This study sought to evaluate the safety and performance of the Igaki-Tamai (Igaki Medical Planning Company, Kyoto, Janpan) biodegradable stent in patients with occlusive superficial femoral artery (SFA) disease.

2016

08-12

新型钴鉻合金可(kě)降解塗層西羅莫司洗脫支架在豬冠狀動脈過度擴張模型中對新生(shēng)內(nèi)膜的影(yǐng)響

評價L-605 钴鉻合金支架平台、聚丙交酯- 乙交酯(PLGA)共聚物載體(tǐ)西羅莫司藥物洗脫支架在小(xiǎo)型豬冠狀動脈過度擴張模型中的安全性和(hé)有(yǒu)效性。

2016

08-12

Stent thrombosis with drug-eluting stents: is the paradigm shifting?

First-generation drug-eluting stents (DES), which impart the controlled release of sirolimus or paclitaxel from durable polymers to the vessel wall, have been consistently shown to reduce the risk of restenosis and target vessel revascularization compared with bare metal stents (BMS).

2016

08-12

Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial

First generation drug-eluting stents (DES) were associated with a high incidence of late stent thrombosis (ST), mainly due to delayed healing and re-endothelization by the durable polymer coating. This study sought to assess the safety and efficacy of the Nano polymer-free sirolimus-eluting stent (SES) in the treatment of patients with de novo coronary artery lesions.

2016

08-12

Real world clinical performance of the zotarolimus eluting coronary stent system in Chinese patients: a prospective, multicenter registry study

Early clinical trials with the Endeavor zotarolimus eluting stent (ZES) in western populations demonstrated low rates of target lesion revascularization with a favorable safety profile including low late stent thrombosis with up to 5 years of follow-up. The aim of this clinical registry study was to evaluate real world clinical performance of the ZES coronary system in Chinese patients.

2016

08-12

Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery

We aimed to investigate short-term outcomes of the XINSOEB bioresorbable sirolimus-eluting scaffold in human coronary artery.

2016

08-12

科學家(jiā)稱五年內(nèi)将3D打印人(rén)類心髒

美國科學家(jiā)表示，未來(lái)幾年之內(nèi)将3D打印組裝完整的心髒組織，并能與患者身體(tǐ)完美地結合在一起。

2016

06-24

阿邁特專家(jiā)委員會(huì)成立

五月的北京，惠風和(hé)暢，春意盎然，鮮花(huā)怒放。在這美好的季節裏，美國工程院院士、美國科學醫(yī)學院院士和(hé)美國發明(míng)家(jiā)學院院士、美國Rice大(dà)學的Antonios G. Mikos教授專程從美國休斯敦飛到北京，與其他幾位專家(jiā)一起從北京飛渡醫療器械有限公司董事長劉青博士手中接過專家(jiā)聘書(shū)，至此，一支由國內(nèi)外頂尖專家(jiā)組成的阿邁特醫(yī)療器(qì)械有(yǒu)限公司專家(jiā)委員會(huì)正式宣告成立。在随後召開(kāi)的第一屆阿邁特專家(jiā)委員會(huì)上(shàng)， Mikos教授對公司研發的3D血管支架精密制(zhì)造專利技(jì)術(shù)給予了高(gāo)度評價。

2016

06-01

< 1...11121314 > 前往 頁

公司信息

北京飛渡醫療器械有限公司

Beijing Advanced Medical Technologies,Ltd.Inc.

 

聯系我們

地址：北京市大(dà)興區(qū)永旺西路26号院中關村醫(yī)療器(qì)械園11号樓

電(diàn)話(huà)：010-6297-7955             郵箱：amt@ametcorp.com

圖片名稱

微信聯系

@Copyright 2022 北京飛渡醫療器械有限公司 All rights reserved   版權所有(yǒu)

京ICP備11028039号    網站(zhàn)建設：中企動力  南京